COVID-19 Treatment Outcomes for Pregnant Women
COVID-19 International Drug Pregnancy Registry
Recruiting
Observational Study
Covid19
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 50
- Sex
- Female
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Pregistry · Industry
Who this trial is looking for
This trial is looking for pregnant women or those who were recently pregnant and have had COVID-19. Participants will help researchers understand how COVID-19 treatments affect pregnancy and newborns.
Are You a Good Fit for This Trial?
You may be able to join if
- I am pregnant or I was pregnant within the last 30 days.
- I am 18 years old or older.
- I have had mild to severe COVID-19 during my pregnancy.
- I have received COVID-19 treatment with specific medications during my pregnancy.
- I was hospitalized but did not receive specific COVID-19 treatments.
- I live in a country that allows this study to take place.
- I have signed the consent form and completed the required initial module.
You may not be able to join if
- I am under 18 years old.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The objective of the COVID-19 International Drug Pregnancy Registry (COVID-PR) is to evaluate obstetric, neonatal, and infant outcomes among women treated with monoclonal antibodies or antiviral drugs indicated for mild, moderate, or severe COVID-19 from the first day of the last menstrual period (LMP) to end of pregnancy. For monoclonal antibodies, the exposure period also includes 90 days prior …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pregnant or recently pregnant (up to 30 days after the end of pregnancy) at time of enrollment
* Age ≥18 years at time of enrollment
* With mild to severe COVID-19 during pregnancy
* Either
* Treated for COVID-19 with at least one of the medications included in Table 1 duri…
Contacts